| Market Cap | — | |
| Enterprise Value | — | |
| Revenue | — | — |
| Gross Profit | — | — |
| EBITDA | — | — |
| Net Income | — | — |
| Diluted EPS | — | — |
| Free Cash Flow | — | — |
| DPS (FY2025) | — |
| Trailing yield | — |
| Payout ratio | 69.0% |
| Growth streak | — |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20252025-12-31 | — | — | reported |
| FY20242024-12-31 | — | — | reported |
| FY20232023-12-31 | — | — | reported |
| Ratio | 2023 | 2024 | 2025 | 2026 | Trend · 4y | vs own |
|---|---|---|---|---|---|---|
| ▾Margins | ||||||
| Gross Margin | 54.32% | 47.20% | 53.91% | — | — | |
| Operating Margin | 22.21% | 13.07% | 19.64% | — | — | |
| NOPAT Margin | 17.27% | 9.58% | 15.42% | — | — | |
| Net Margin | 16.90% | 7.98% | 14.04% | — | — | |
| FCF Margin | 12.82% | 17.78% | 19.52% | — | — | |
| FCFF Margin | 14.26% | 19.83% | 21.45% | — | — | |
| FCFE Margin | 17.29% | 7.21% | 48.67% | — | — | |
| OCF Margin | 23.19% | 26.60% | 29.38% | — | — | |
| Gross Profitability | 34.25% | 11.91% | 13.71% | — | — | |
| Capex Intensity | 10.37% | 8.82% | 9.86% | — | — | |
| ▸Returns on Capital · 6 ratios | ||||||
| ▸DuPont factors (ROE drivers) · 4 ratios | ||||||
| ▸Earnings quality · 5 ratios | ||||||
| ▸Liquidity & coverage · 7 ratios | ||||||
| ▸Leverage · 8 ratios | ||||||
| ▸Working capital · 8 ratios | ||||||
| ▸Capital allocation · 5 ratios | ||||||
| ▸Other · 1 ratios | ||||||
The five drivers multiply to 5.6% vs reported ROE 5.3%. High ROE from margin and turnover is earned; from the equity multiplier it is borrowed.
| Line | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | €2.40B | €3.83B | €4.16B |
| YoY % | +59.6% | +8.5% | |
| Cost of Revenue | €1.10B | €2.02B | €1.92B |
| YoY % | +84.4% | -5.3% | |
| Gross Profit | €1.30B | €1.81B | €2.24B |
| YoY % | +38.7% | +23.9% | |
| R&D Expense | €270.7M | €413.2M | €463.8M |
| YoY % | +52.6% | +12.2% | |
| SG&A Expense | €128.7M | €214.6M | €223.2M |
| YoY % | +66.7% | +4.0% | |
| Operating Income | €533.6M | €501.0M | €816.7M |
| YoY % | -6.1% | +63.0% | |
| Interest Expense | €44.3M | €107.3M | €102.2M |
| YoY % | +142.2% | -4.8% | |
| Interest & Investment Income | €37.8M | €26.9M | €35.4M |
| YoY % | -28.8% | +31.6% | |
| Equity Method Income | -€2.4M | -€3.5M | -€6.5M |
| Pretax Income | €524.7M | €417.1M | €743.4M |
| YoY % | -20.5% | +78.2% | |
| Income Tax | €116.8M | €111.3M | €159.8M |
| YoY % | -4.7% | +43.6% | |
| Net Income (incl. NCI) | €407.9M | €305.8M | €583.6M |
| YoY % | -25.0% | +90.8% | |
| Minority Interest (P&L) | €2.0M | €0 | €0 |
| YoY % | -100.0% | ||
| Net Income | €405.9M | €305.8M | €583.6M |
| YoY % | -24.7% | +90.8% | |
| EPS (Basic) | €1.47 | €0.67 | €1.25 |
| YoY % | -54.4% | +86.6% | |
| EPS (Diluted) | €1.46 | €0.67 | €1.25 |
| YoY % | -54.1% | +86.6% |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
